Forty human clinical Mycobacterium avium-M. intracellulare complex strains isolated in Greece were characterized to the species level by PCR with three sets of primers specific for one or both species. M. avium predominated in both human immunodeficiency virus-positive and -negative patients, but the frequency of M. intracellulare isolation appeared to be higher in the latter.
Mycobacterial species are infectious agents of serious human diseases, such as tuberculosis and leprosy (7) . Environmental mycobacteria, on the other hand, such as those of the Mycobacterium avium-M. intracellulare complex (MAC), tend to cause opportunistic infections only (16) . Scrofula, a disease which was already known to Hippocrates and was later defined as tuberculous cervical lymphadenitis, was initially attributed to the pathogenic action of Mycobacterium scrofulaceum and the M. tuberculosis group. Since the late 1950s, when the first cases of cervical lymphadenitis caused by MAC were diagnosed, the frequency of MAC isolation has increased, with MAC replacing M. scrofulaceum as the most prevalent species in the etiology of disease (19) . The clinical significance of MAC infection has become more important in patients immunocompromised by AIDS (11) . MAC is, in fact, the organism most commonly isolated from bacteremic patients with AIDS and is believed to greatly impair their quality of life and to reduce their life expectancy (12) . In the developed world, the incidence of MAC in AIDS patients can be as high as 40% and the detection rate at the time of autopsy can be as high as 53% (11) .
MAC consists of two species that are genetically distinct but difficult to discriminate: M. avium, which predominates among MAC isolates from both AIDS patients and non-AIDS patients (87 to 98% and 58 to 60%, respectively), and M. intracellulare, which is more frequently isolated among non-AIDS patients (5) . Differentiation of clinical isolates into either M. avium or M. intracellulare is of clinical and epidemiological interest. Although M. avium and M. intracellulare strains generally cause indistinguishable infections, M. avium serotypes are more frequently isolated from the environment (6) and predominate over M. intracellulare in all clinical conditions in which MAC is encountered, such as AIDS and cervical lymphadenopathies in children (19, 21) . On the other hand, M. intracellulare among AIDS patients seems to be isolated preferentially from sputum (21) . However, the conventional serotyping method cannot always easily distinguish between these two closely related species and requires large amounts of these slow-growing organisms (12) . Therefore, molecular diagnostic methods, which can be performed rapidly with small numbers of cells, are particularly helpful in this case (18) . For example, sequencing of the 16S rRNA gene has been used to clarify the taxonomy within MAC (8); however, this methodology is limited in practice to reference laboratories. Recently, Thierry et al. successfully used species-specific primers for the selective amplification of a 187-bp fragment within the DT6 region of the M. avium genome or of a 666-bp fragment within the DT1 regions of both M. avium and M. intracellulare genomes (17) . Use of these primers for characterization of clinical MAC strains to the species level has been demonstrated to provide an inexpensive and at least equally sensitive alternative to identification by commercially available DNA probes (3) .
The aim of the present study was to determine the frequency of isolation of M. avium and M. intracellulare from AIDS patients and from human immunodeficiency virus (HIV)-negative patients in Greece, a part of the world not previously surveyed in this manner. During the period 1991 to 1996, 430 specimens from HIV-positive patients were referred to the Sotiria Hospital for Chest Disease. A total of 45 (10%) were positive for MAC, compared with 32 (7%) that were positive for Mycobacterium tuberculosis. These MAC strains were isolated from the following clinical specimens: blood (35 specimens), sputum (8 specimens), gastric lavage (1 specimen), and urine (1 specimen). During 1991 to 1995, 194 lymph node biopsies were taken from HIV-negative children with cervical lymphadenopathy. A total of 22 (11%) were positive for MAC, compared to 17 (9%) that were positive for M. tuberculosis and 2 (1%) that were positive for other, fast-growing mycobacteria. Finally, during 1991 to 1993, 38 MAC strains were isolated from 1,238 specimens (mostly sputum, pericardial tissue, urine, feces, bronchoalveolar lavage, and blood) originating from HIV-negative adults.
In the present study, 40 human clinical isolates that were identified as MAC by a combination of biochemical tests and a DNA-rRNA hybridization test (SNAP; Syngene) were tested. Of these, 20 and 20 had been isolated from AIDS patients and HIV-seronegative patients, respectively. The latter consisted of 12 children suffering from cervical lymphadenopathy and 8 adults with pulmonary or intra-abdominal disease. Multiple sweeps from each isolate grown in Loewenstein-Jensen agar were inoculated in 10 ml of Middlebrook 7H9 broth (BBL), which was supplemented with albumin fraction V, dextrose, and catalase (BBL), and the mixture was incubated for 5 to 10 days at 37°C with agitation. Resulting growth was tested by the Ziehl Neelsen stain for the presence of acid-fast bacilli and by the Gram stain for the presence of contaminants. For DNA extraction, 2 ml from each broth was centrifuged. The cell pellet was resuspended in 1 ml of Middlebrook 7H9 containing 100 g of D-cycloserine (Sigma) per ml in order to weaken the mycobacterial cell wall (17) and 200 g of lysozyme (Sigma) per ml, and the suspension was incubated for 48 h at 37°C. After centrifugation, the cell pellet was resuspended in 500 l of a solution containing 50 mM Tris (pH 8.0), 50 mM EDTA, 10 mM NaCl, 0.5% sodium dodecyl sulfate, and 60 g of proteinase K (Sigma) per ml and the suspension was incubated at 55°C for a further 18 h. Following standard phenol-chloroform extraction and ethanol precipitation, DNA was dissolved in 50 l of sterile distilled water and stored at Ϫ20°C until needed. For PCR, the following primers were used: AV6 (5Ј-GATGGCCGGGAGACGATCTATGCCGGCGTAC-3Ј) and AV7 (5Ј-TCGAGGAAGGCCTGTTCCGACCGTGTTGCG C-3Ј) for the amplification of a 187-bp fragment within the DT6 region of the M. avium genome, IN38 (5Ј-GAACGCCCG TTGGCTGGCCATTCACGAAGGAG-3Ј) and IN41 (5Ј-TC GAGGAAGGCCTGTCCGACCGTGTTGCGC-3Ј) for the amplification of a 666-bp fragment within the DT1 region present in both the M. avium and the M. intracellulare genomes (17) , and P1 (5Ј-GCCGCCGAAACGATCTAC-3Ј) and P2 (5Ј-AGGTGGCG TCGAGGAAGAC-3Ј) for the amplification of a 487-bp fragment within the IS1245 insertion sequence, which was shown to be present in several copies in M. avium but not in M. intracellulare clinical isolates (9) . Amplification reactions were performed in 50-l reaction mixtures containing 50 mM Tris-HCl (pH 8.5), 2 mM MgCl 2 , 100 pmol of each primer, 200 M (each) the four deoxyribonucleoside triphosphates (dATP, dGTP, dTTP, and dCTP), 5 l of template DNA, and 2 U of Taq DNA polymerase (Tib Molbiol, Frankfurt, Germany). The amplification mixture was overlaid with 2 drops of paraffin oil. Amplification consisted of 35 cycles of denaturation at 94°C for 1 min, annealing at 60°C for 1 min, and DNA synthesis at 72°C for 1 min with a Power Block System thermocycler (Ericomp, Inc.). Each amplification experiment included control reaction mixtures without DNA and with DNA extracted from M. avium Pasteur Institute reference strain 140310002 and from M. intracellulare Pasteur Institute reference strain 14031001. Amplification products were analyzed by electrophoresis on a 2% agarose gel in 0.5ϫ Tris-borate-EDTA. Plasmid pBR322 DNA digested with HinfI (New England Biolabs) was used to provide DNA size markers. The results were photographed under UV illumination after ethidium bromide staining.
As summarized in Table 1 , 19 of the 20 blood isolates from the AIDS group were M. avium (Fig. 1A, lanes 5 to 7) and only one was M. intracellulare (Fig. 1B, lane 7) . Similarly, as summarized in Table 1 , M. avium was present in 11 lymph node biopsies from children with cervical lymphadenopathy (Fig.  1A, lanes 8 to 10) , whereas M. intracellulare was present only in 1 (Fig. 1B, lane 8) . No amplification products with either set of (Fig. 1C) . This powerful marker has been used to confirm the genetic identity of different morphotypes of a single M. avium strain (21) and has the same discriminatory ability whether it is used in a conventional Southern blot-based restriction fragment length polymorphism assay or in a PCR assay (15) . Apart from human clinical isolates, it has also been shown to be present in porcine M. avium strains (1). Our results suggest that it will be useful in typing M. avium strains from HIVnegative as well as -positive patients. The use of DNA amplification techniques for the diagnosis of slow-growing, fastidious infectious pathogens such as the Mycobacterium species belonging to MAC is essential for the timely onset of chemotherapy, which can lead to improvement of symptoms, clearing of bacilli, and, in some instances, an increased rate of survival in patients with AIDS suffering from MAC disease (10, 14) . For these reasons, DNA amplification techniques are currently being optimized with respect to their sensitivity and specificity in a number of laboratories (2, 4, 13) . We have used a PCR with primers specific for the M. avium genome or for both the M. avium and the M. intracellulare genomes (17) to differentiate MAC strains from a variety of infections and clinical specimens into either species. Our study suggests that while M. avium is prevalent in all cases, M. intracellulare may be isolated from children with cervical lymphadenopathy more frequently than from AIDS patients.
